Skip to main content
SGLT2 inhibitors: No benefit or harm in hospitalized COVID-19
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
SGLT2 inhibitors: No benefit or harm in hospitalized COVID-19
User login
Username
Password
Reset your password
Concept
Lead
score
COVID-19
1
1
SGLT2 Inhibitor
0
0.99
Type 2 Diabetes Mellitus
0
0.82
Renal Failure
0
0.35
Renal Disease
0
0.28
Chronic Kidney Disease
0
0.26
Acute Kidney Injury
0
0.25
Kidney
0
0.24
Meta-Analysis
0
0.24
Hospital
0
0.2
Heart
0
0.16
Hemodialysis
0
0.15
Heart Failure (HF)
0
0.14
Blood
0
0.08
Injury
0
0.08
Mechanical Ventilation
0
0.07
Thromboembolism
0
0.07
Wound Management
0
0.07
Specialty
Lead
score
Cardiology
1
1
Internal Medicine
0
0.6
Pulmonary Medicine
0
0.8
Infectious Diseases
0
0.9
Nephrology
0
0.4
Diabetes & Endocrinology
0
0.7
Family Medicine/Primary Care
0
0.5
Edit Tags